Clinical trial
Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
NCT02823366 is registered in ClinicalTrials.gov with Xijing Hospital of Digestive Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
- Lead sponsor
- Xijing Hospital of Digestive Diseases
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- January 31, 2016
- Completion date
- December 31, 2023
- Enrollment
- 104 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
primary biliary cirrhosis